Imfinzi® (durvalumab)
for Liver Cancer

Imfinzi (durvalumab) is an immunotherapy used to treat various cancers, including non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), bile duct cancer, gallbladder cancer, hepatocellular carcinoma, and endometrial cancer. It may help improve overall survival, reduce cancer spread, and shrink tumors. Imfinzi works by enhancing the immune system's ability to recognize and attack cancer cells.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Liver Cancer